1 |
Chitosan as a promising materials for the construction of nanocarriers for diabetic retinopathy: an updated review |
|
|
| Yan Lv, Chenglei Zhai, Gang Sun, Yangfang He |
|
| Journal of Biological Engineering. 2024; 18(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
Nanoformulations of flavonoids for diabetes and microvascular diabetic complications |
|
|
| Kopal Agarawal, Yogesh Anant Kulkarni, Sarika Wairkar |
|
| Drug Delivery and Translational Research. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
Permeability, anti-inflammatory and anti-VEGF profiles of steroidal-loaded cationic nanoemulsions in retinal pigment epithelial cells under oxidative stress |
|
|
| Ana R. Fernandes, Tiago dos Santos, Pedro L. Granja, Elena Sanchez-Lopez, Maria L. Garcia, Amelia M. Silva, Eliana B. Souto |
|
| International Journal of Pharmaceutics. 2022; : 121615 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration |
|
|
| Jose Navarro-Partida, Juan Carlos Altamirano-Vallejo, Luis Abraham Aceves Franco, Jesús Gonzalez-Cortes, Sergio Hernandez-Da Mota, Jose Gerardo García-Aguirre, Carlos David Azuara-Galindo, Carlos Rodrigo Castro-Castaneda, Juan Armendariz-Borunda, Arturo Santos |
|
| Pharmaceutics. 2021; 13(9): 1491 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications |
|
|
| M.L. Formica, G.V. Ullio Gamboa, L.I. Tártara, J.D. Luna, J.P. Benoit, S.D. Palma |
|
| International Journal of Pharmaceutics. 2020; 573: 118795 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
6 |
Clearance of autophagy-associated dying retinal pigment epithelial cells – a possible source for inflammation in age-related macular degeneration |
|
|
| M Szatmári-Tóth, E Kristóf, Z Veréb, S Akhtar, A Facskó, L Fésüs, A Kauppinen, K Kaarniranta, G Petrovski |
|
| Cell Death & Disease. 2016; 7(9): e2367 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
7 |
Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells |
|
|
| Siva P. Kambhampati,Manoj K. Mishra,Panagiotis Mastorakos,Yumin Oh,Gerard A. Lutty,Rangaramanujam M. Kannan |
|
| European Journal of Pharmaceutics and Biopharmaceutics. 2015; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
8 |
Triamcinolone acetonide nanoparticles incorporated in thermoreversible gels for age-related macular degeneration |
|
|
| Anjali Hirani,Aditya Grover,Yong W. Lee,Yashwant Pathak,Vijaykumar Sutariya |
|
| Pharmaceutical Development and Technology. 2014; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
9 |
Drug safety evaluation of intravitreal triamcinolone acetonide |
|
|
| Daniele Veritti, Andrea Di Giulio, Valentina Sarao, Paolo Lanzetta |
|
| Expert Opinion on Drug Safety. 2011; : 1 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
10 |
Pharmacokinetics of triamcinolone acetonide for the treatment of macular edema |
|
|
| Taygan Yilmaz, Miguel Cordero-Coma, Thomas J Federici |
|
| Expert Opinion on Drug Metabolism & Toxicology. 2011; : 1 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
11 |
Association of ranibizumab (Lucentis®) or bevacizumab (Avastin®) with dexamethasone and triamcinolone acetonide: An in vitro stability assessment |
|
|
| Marieke Veurink, Cinzia Stella, Cyrus Tabatabay, Constantin J. Pournaras, Robert Gurny |
|
| European Journal of Pharmaceutics and Biopharmaceutics. 2011; 78(2): 271 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
12 |
Intravitreal triamcinolone |
|
|
| Tao, Y., Jonas, J.B. |
|
| Ophthalmologica. 2010; 225(1): 1-20 |
|
| [Pubmed] [Google Scholar] |
|
13 |
Intravitreal bevacizumab combined with intravitreal triamcinolone for therapy-resistant exudative age-related macular degeneration |
|
|
| Tao, Y., Jonas, J.B. |
|
| Journal of Ocular Pharmacology and Therapeutics. 2010; 26(2): 207-211 |
|
| [Pubmed] [Google Scholar] |
|
14 |
Intravitreal Bevacizumab Combined With Intravitreal Triamcinolone for Therapy-Resistant Exudative Age-Related Macular Degeneration |
|
|
| Yong Tao,Jost B. Jonas |
|
| Journal of Ocular Pharmacology and Therapeutics. 2010; 26(2): 207 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
15 |
Comparing Pegaptanib and Triamcinolone Efficacy in the Rat Choroidal Neovascularization Model |
|
|
| Criswell, M.H. and Hu, W.Z. and Steffens, T.J. and Li, R. and Margaron, P. |
|
| Archives of Ophthalmology. 2008; 126(7): 946 |
|
| [Pubmed] [Google Scholar] |
|